Warning
This job advert has expired and applications have closed.
12560 - Postdoctoral Research Fellow
| Posting date: | 28 May 2025 |
|---|---|
| Salary: | £40,497 to £48,149 per year |
| Hours: | Full time |
| Closing date: | 11 June 2025 |
| Location: | Edinburgh, Scotland |
| Remote working: | On-site only |
| Company: | University of Edinburgh |
| Job type: | Contract |
| Job reference: | 12560 |
Summary
Grade UE07: £40,497 - £48,149 per annum
CMVM / Institute for Regeneration and Repair / Centre for Inflammation Research
Full-time: 35 hours per week
Fixed-term: 1 year
The Opportunity:
We are looking for a Postdoctoral Research Fellow with expertise in tissue injury and repair and assessing the role of the immune system in regulating these processes. The research fellow will dissect the cell-specific mechanisms by which PFKFB3 regulates the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD) and assess the impact of PFKFB3 inhibition on liver fibrosis. This will be achieved via the detailed analysis of samples from rodent and human preclinical models of MASLD.
Your skills and attributes for success:
A PhD (or will shortly attain) in, molecular or cell biology, immunology, regenerative medicine, or a related discipline.
Home Office Personal License (PIL).
Practical experience with in vivo models, immunofluorescence labelling and molecular biology.
Tissue sectioning and histological/ immunohistochemical techniques.
Extensive experience of operating spectral flow cytometry (e.g.: Cytek Aurora system) and FACS.
CMVM / Institute for Regeneration and Repair / Centre for Inflammation Research
Full-time: 35 hours per week
Fixed-term: 1 year
The Opportunity:
We are looking for a Postdoctoral Research Fellow with expertise in tissue injury and repair and assessing the role of the immune system in regulating these processes. The research fellow will dissect the cell-specific mechanisms by which PFKFB3 regulates the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD) and assess the impact of PFKFB3 inhibition on liver fibrosis. This will be achieved via the detailed analysis of samples from rodent and human preclinical models of MASLD.
Your skills and attributes for success:
A PhD (or will shortly attain) in, molecular or cell biology, immunology, regenerative medicine, or a related discipline.
Home Office Personal License (PIL).
Practical experience with in vivo models, immunofluorescence labelling and molecular biology.
Tissue sectioning and histological/ immunohistochemical techniques.
Extensive experience of operating spectral flow cytometry (e.g.: Cytek Aurora system) and FACS.